Global Breath Molecular Diagnosis Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Breath Molecular Diagnosis market size is predicted to grow from US$ 284 million in 2025 to US$ 567 million in 2031; it is expected to grow at a CAGR of 12.2% from 2025 to 2031.
Exhaled breath molecular diagnosis is an emerging in vitro diagnostic (IVD) technology. Generally speaking, in vitro diagnosis requires the use of diagnostic reagents and equipment to analyze samples such as blood or urine. Sampling is done first and then analysis is done. Cells, microorganisms and biochemical molecules can be analyzed. It is mainly used for the diagnosis of blood circulation or systemic diseases. Exhaled breath molecular diagnosis does not require diagnostic reagents, and sampling and analysis can be performed at the same time. The gas molecules produced by cell and microbial metabolism are analyzed, which is particularly suitable for the diagnosis of respiratory and digestive diseases. Exhaled breath molecular diagnosis complements blood tests and imaging diagnosis. Like existing in vitro diagnosis, exhaled breath molecular diagnosis is also divided into two categories: professional laboratories and point-of-care diagnosis (POCT). Professional laboratories use laboratory analysis equipment such as gas chromatography, mass spectrometry and spectroscopy to perform exhaled breath analysis on patients' exhaled gas sampling bags or gas sampling tubes; due to the lack of exhaled breath sensor products, Europe and the United States currently provide analytical services for exhaled metabolomics of H2, CH4 and VOC (volatile organic compounds) through professional laboratories. Point-of-care diagnosis (POCT) uses exhaled breath detection sensors, which integrate sampling and analysis. It only takes a few seconds for patients to sample their exhaled breath, and only tens of seconds for the instrument to analyze the results.
Exhaled breath molecular diagnostic equipment is classified as a low-risk medical device by European and American drug regulatory authorities. The US FDA believes that breath testing will affect the results of medical diagnosis. As a Class II medical device, it only tests and certifies the performance of breath testing. The EU regulates it as a special Class I medical device similar to a sphygmomanometer. It only needs to be tested by itself or by a third-party laboratory according to the EN standard. Therefore, exhaled breath molecular diagnostic equipment was first listed in Europe, and there are a large number of them now. China currently regulates exhaled breath molecular diagnostic equipment as a Class II medical device, and it takes a long time to register. At present, most medical devices related to exhaled breath molecular diagnostic technology are in the market cultivation or introduction stage, requiring a large number of clinical trials, certification and registration.
POCT based on exhaled breath molecular diagnosis can provide detection items that blood test POCT lacks, such as detection of airway inflammation and gastrointestinal flora metabolic disorders. Moreover, POCT based on exhaled breath molecular diagnosis does not require blood drawing, and has the characteristics of non-invasive, instant, and biopsy. It can be used to make up for the shortcomings of in vitro diagnosis such as blood tests and imaging, avoid the risks of invasive in vivo diagnosis, and is more suitable for the use of common diseases and chronic diseases in hospitals, grassroots physical examinations, and family self-examination. In recent years, exhaled breath molecular diagnosis technology has been increasingly valued by domestic and foreign governments, research and development institutions, and related medical organizations. Various organizations and institutions have formulated relevant policies, development plans, and standard guidelines to jointly promote the rapid development of clinical technology for exhaled breath molecular diagnosis.
Exhaled breath molecular diagnosis or breath testing belongs to the emerging field of POCT technology. At present, the Helicobacter pylori breath test with the largest market size has a market history of less than 25 years, and the development of the inflammatory breath test product with the greatest market potential has only been 10 years, while breath testing technologies such as gastrointestinal flora metabolic disorders are still in the market cultivation stage. In addition, breath detection technologies such as breath NH3, H2S, VOC (volatile organic compounds), breath metabolomics and olfactory artificial intelligence (electronic nose) are still in clinical trials or waiting for drug regulatory certification and approval.
In the past 30 years, with the gradual development of related technologies including breath detection abroad, the rapid growth of the domestic economy and the continuous development of the medical and health industry have provided a broad market space for the widespread application of this technology in China. At the same time, the development of domestic breath detection technology is almost synchronized with that of foreign countries, covering almost all areas of foreign breath detection, including the research of breath metabolomics and olfactory artificial intelligence, and many technologies are even ahead of foreign countries. It is one of the few emerging technology fields that may form a global leading breath detection in China.
With the continuous advancement of the construction of the PCCM system, the demand for breath analysis products in secondary and tertiary hospitals will further expand. Portable instrument products, handheld instrument products and other products for primary hospitals and home terminals are constantly being developed, and product application scenarios and usage needs will be further expanded.
With the development of science and technology and artificial intelligence, future breathalyzers will be more intelligent and automated, with functions such as automatic identification, data analysis and report generation, reducing human intervention and improving diagnostic accuracy and efficiency.
LP Information, Inc. (LPI) ' newest research report, the “Breath Molecular Diagnosis Industry Forecast” looks at past sales and reviews total world Breath Molecular Diagnosis sales in 2024, providing a comprehensive analysis by region and market sector of projected Breath Molecular Diagnosis sales for 2025 through 2031. With Breath Molecular Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breath Molecular Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Breath Molecular Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breath Molecular Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breath Molecular Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breath Molecular Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breath Molecular Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Breath Molecular Diagnosis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Breath Molecular Diagnosis market?
What factors are driving Breath Molecular Diagnosis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Breath Molecular Diagnosis market opportunities vary by end market size?
How does Breath Molecular Diagnosis break out by Type, by Application?
The global Breath Molecular Diagnosis market size is predicted to grow from US$ 284 million in 2025 to US$ 567 million in 2031; it is expected to grow at a CAGR of 12.2% from 2025 to 2031.
Exhaled breath molecular diagnosis is an emerging in vitro diagnostic (IVD) technology. Generally speaking, in vitro diagnosis requires the use of diagnostic reagents and equipment to analyze samples such as blood or urine. Sampling is done first and then analysis is done. Cells, microorganisms and biochemical molecules can be analyzed. It is mainly used for the diagnosis of blood circulation or systemic diseases. Exhaled breath molecular diagnosis does not require diagnostic reagents, and sampling and analysis can be performed at the same time. The gas molecules produced by cell and microbial metabolism are analyzed, which is particularly suitable for the diagnosis of respiratory and digestive diseases. Exhaled breath molecular diagnosis complements blood tests and imaging diagnosis. Like existing in vitro diagnosis, exhaled breath molecular diagnosis is also divided into two categories: professional laboratories and point-of-care diagnosis (POCT). Professional laboratories use laboratory analysis equipment such as gas chromatography, mass spectrometry and spectroscopy to perform exhaled breath analysis on patients' exhaled gas sampling bags or gas sampling tubes; due to the lack of exhaled breath sensor products, Europe and the United States currently provide analytical services for exhaled metabolomics of H2, CH4 and VOC (volatile organic compounds) through professional laboratories. Point-of-care diagnosis (POCT) uses exhaled breath detection sensors, which integrate sampling and analysis. It only takes a few seconds for patients to sample their exhaled breath, and only tens of seconds for the instrument to analyze the results.
Exhaled breath molecular diagnostic equipment is classified as a low-risk medical device by European and American drug regulatory authorities. The US FDA believes that breath testing will affect the results of medical diagnosis. As a Class II medical device, it only tests and certifies the performance of breath testing. The EU regulates it as a special Class I medical device similar to a sphygmomanometer. It only needs to be tested by itself or by a third-party laboratory according to the EN standard. Therefore, exhaled breath molecular diagnostic equipment was first listed in Europe, and there are a large number of them now. China currently regulates exhaled breath molecular diagnostic equipment as a Class II medical device, and it takes a long time to register. At present, most medical devices related to exhaled breath molecular diagnostic technology are in the market cultivation or introduction stage, requiring a large number of clinical trials, certification and registration.
POCT based on exhaled breath molecular diagnosis can provide detection items that blood test POCT lacks, such as detection of airway inflammation and gastrointestinal flora metabolic disorders. Moreover, POCT based on exhaled breath molecular diagnosis does not require blood drawing, and has the characteristics of non-invasive, instant, and biopsy. It can be used to make up for the shortcomings of in vitro diagnosis such as blood tests and imaging, avoid the risks of invasive in vivo diagnosis, and is more suitable for the use of common diseases and chronic diseases in hospitals, grassroots physical examinations, and family self-examination. In recent years, exhaled breath molecular diagnosis technology has been increasingly valued by domestic and foreign governments, research and development institutions, and related medical organizations. Various organizations and institutions have formulated relevant policies, development plans, and standard guidelines to jointly promote the rapid development of clinical technology for exhaled breath molecular diagnosis.
Exhaled breath molecular diagnosis or breath testing belongs to the emerging field of POCT technology. At present, the Helicobacter pylori breath test with the largest market size has a market history of less than 25 years, and the development of the inflammatory breath test product with the greatest market potential has only been 10 years, while breath testing technologies such as gastrointestinal flora metabolic disorders are still in the market cultivation stage. In addition, breath detection technologies such as breath NH3, H2S, VOC (volatile organic compounds), breath metabolomics and olfactory artificial intelligence (electronic nose) are still in clinical trials or waiting for drug regulatory certification and approval.
In the past 30 years, with the gradual development of related technologies including breath detection abroad, the rapid growth of the domestic economy and the continuous development of the medical and health industry have provided a broad market space for the widespread application of this technology in China. At the same time, the development of domestic breath detection technology is almost synchronized with that of foreign countries, covering almost all areas of foreign breath detection, including the research of breath metabolomics and olfactory artificial intelligence, and many technologies are even ahead of foreign countries. It is one of the few emerging technology fields that may form a global leading breath detection in China.
With the continuous advancement of the construction of the PCCM system, the demand for breath analysis products in secondary and tertiary hospitals will further expand. Portable instrument products, handheld instrument products and other products for primary hospitals and home terminals are constantly being developed, and product application scenarios and usage needs will be further expanded.
With the development of science and technology and artificial intelligence, future breathalyzers will be more intelligent and automated, with functions such as automatic identification, data analysis and report generation, reducing human intervention and improving diagnostic accuracy and efficiency.
LP Information, Inc. (LPI) ' newest research report, the “Breath Molecular Diagnosis Industry Forecast” looks at past sales and reviews total world Breath Molecular Diagnosis sales in 2024, providing a comprehensive analysis by region and market sector of projected Breath Molecular Diagnosis sales for 2025 through 2031. With Breath Molecular Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breath Molecular Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Breath Molecular Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breath Molecular Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breath Molecular Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breath Molecular Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breath Molecular Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Breath Molecular Diagnosis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- C13 Type
- NO Type
- H2/CO Type
- VOCs Type
- Hospital
- Clinic
- Physical Examination Center
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NIOX Group plc
- Headway
- Sunvou Medical Electronics Co
- Richen Holding
- Meridian Bioscience
- CAPNIA, Inc.
- Kibion??
- Otsuka Electronics
- LEYI BIOLOGY
- Eco Physics AG
- Shenzhen Breax
- QUINTRON
- Beijing Wanliandaxinke Instruments Co
- SIMES SIKMA
- Beijing Safe Heart Technology
- e-LinkCare Meditech Co
- ChromX Health
- Huiyuen Tech
What is the 10-year outlook for the global Breath Molecular Diagnosis market?
What factors are driving Breath Molecular Diagnosis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Breath Molecular Diagnosis market opportunities vary by end market size?
How does Breath Molecular Diagnosis break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Breath Molecular Diagnosis Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Breath Molecular Diagnosis by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Breath Molecular Diagnosis by Country/Region, 2020, 2024 & 2031
2.2 Breath Molecular Diagnosis Segment by Type
2.2.1 C13 Type
2.2.2 NO Type
2.2.3 H2/CO Type
2.2.4 VOCs Type
2.3 Breath Molecular Diagnosis Sales by Type
2.3.1 Global Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
2.3.2 Global Breath Molecular Diagnosis Revenue and Market Share by Type (2020-2025)
2.3.3 Global Breath Molecular Diagnosis Sale Price by Type (2020-2025)
2.4 Breath Molecular Diagnosis Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Physical Examination Center
2.4.4 Other
2.5 Breath Molecular Diagnosis Sales by Application
2.5.1 Global Breath Molecular Diagnosis Sale Market Share by Application (2020-2025)
2.5.2 Global Breath Molecular Diagnosis Revenue and Market Share by Application (2020-2025)
2.5.3 Global Breath Molecular Diagnosis Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Breath Molecular Diagnosis Breakdown Data by Company
3.1.1 Global Breath Molecular Diagnosis Annual Sales by Company (2020-2025)
3.1.2 Global Breath Molecular Diagnosis Sales Market Share by Company (2020-2025)
3.2 Global Breath Molecular Diagnosis Annual Revenue by Company (2020-2025)
3.2.1 Global Breath Molecular Diagnosis Revenue by Company (2020-2025)
3.2.2 Global Breath Molecular Diagnosis Revenue Market Share by Company (2020-2025)
3.3 Global Breath Molecular Diagnosis Sale Price by Company
3.4 Key Manufacturers Breath Molecular Diagnosis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Breath Molecular Diagnosis Product Location Distribution
3.4.2 Players Breath Molecular Diagnosis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BREATH MOLECULAR DIAGNOSIS BY GEOGRAPHIC REGION
4.1 World Historic Breath Molecular Diagnosis Market Size by Geographic Region (2020-2025)
4.1.1 Global Breath Molecular Diagnosis Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Breath Molecular Diagnosis Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Breath Molecular Diagnosis Market Size by Country/Region (2020-2025)
4.2.1 Global Breath Molecular Diagnosis Annual Sales by Country/Region (2020-2025)
4.2.2 Global Breath Molecular Diagnosis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Breath Molecular Diagnosis Sales Growth
4.4 APAC Breath Molecular Diagnosis Sales Growth
4.5 Europe Breath Molecular Diagnosis Sales Growth
4.6 Middle East & Africa Breath Molecular Diagnosis Sales Growth
5 AMERICAS
5.1 Americas Breath Molecular Diagnosis Sales by Country
5.1.1 Americas Breath Molecular Diagnosis Sales by Country (2020-2025)
5.1.2 Americas Breath Molecular Diagnosis Revenue by Country (2020-2025)
5.2 Americas Breath Molecular Diagnosis Sales by Type (2020-2025)
5.3 Americas Breath Molecular Diagnosis Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breath Molecular Diagnosis Sales by Region
6.1.1 APAC Breath Molecular Diagnosis Sales by Region (2020-2025)
6.1.2 APAC Breath Molecular Diagnosis Revenue by Region (2020-2025)
6.2 APAC Breath Molecular Diagnosis Sales by Type (2020-2025)
6.3 APAC Breath Molecular Diagnosis Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Breath Molecular Diagnosis by Country
7.1.1 Europe Breath Molecular Diagnosis Sales by Country (2020-2025)
7.1.2 Europe Breath Molecular Diagnosis Revenue by Country (2020-2025)
7.2 Europe Breath Molecular Diagnosis Sales by Type (2020-2025)
7.3 Europe Breath Molecular Diagnosis Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Breath Molecular Diagnosis by Country
8.1.1 Middle East & Africa Breath Molecular Diagnosis Sales by Country (2020-2025)
8.1.2 Middle East & Africa Breath Molecular Diagnosis Revenue by Country (2020-2025)
8.2 Middle East & Africa Breath Molecular Diagnosis Sales by Type (2020-2025)
8.3 Middle East & Africa Breath Molecular Diagnosis Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Breath Molecular Diagnosis
10.3 Manufacturing Process Analysis of Breath Molecular Diagnosis
10.4 Industry Chain Structure of Breath Molecular Diagnosis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Breath Molecular Diagnosis Distributors
11.3 Breath Molecular Diagnosis Customer
12 WORLD FORECAST REVIEW FOR BREATH MOLECULAR DIAGNOSIS BY GEOGRAPHIC REGION
12.1 Global Breath Molecular Diagnosis Market Size Forecast by Region
12.1.1 Global Breath Molecular Diagnosis Forecast by Region (2026-2031)
12.1.2 Global Breath Molecular Diagnosis Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Breath Molecular Diagnosis Forecast by Type (2026-2031)
12.7 Global Breath Molecular Diagnosis Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 NIOX Group plc
13.1.1 NIOX Group plc Company Information
13.1.2 NIOX Group plc Breath Molecular Diagnosis Product Portfolios and Specifications
13.1.3 NIOX Group plc Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 NIOX Group plc Main Business Overview
13.1.5 NIOX Group plc Latest Developments
13.2 Headway
13.2.1 Headway Company Information
13.2.2 Headway Breath Molecular Diagnosis Product Portfolios and Specifications
13.2.3 Headway Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Headway Main Business Overview
13.2.5 Headway Latest Developments
13.3 Sunvou Medical Electronics Co
13.3.1 Sunvou Medical Electronics Co Company Information
13.3.2 Sunvou Medical Electronics Co Breath Molecular Diagnosis Product Portfolios and Specifications
13.3.3 Sunvou Medical Electronics Co Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sunvou Medical Electronics Co Main Business Overview
13.3.5 Sunvou Medical Electronics Co Latest Developments
13.4 Richen Holding
13.4.1 Richen Holding Company Information
13.4.2 Richen Holding Breath Molecular Diagnosis Product Portfolios and Specifications
13.4.3 Richen Holding Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Richen Holding Main Business Overview
13.4.5 Richen Holding Latest Developments
13.5 Meridian Bioscience
13.5.1 Meridian Bioscience Company Information
13.5.2 Meridian Bioscience Breath Molecular Diagnosis Product Portfolios and Specifications
13.5.3 Meridian Bioscience Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Meridian Bioscience Main Business Overview
13.5.5 Meridian Bioscience Latest Developments
13.6 CAPNIA, Inc.
13.6.1 CAPNIA, Inc. Company Information
13.6.2 CAPNIA, Inc. Breath Molecular Diagnosis Product Portfolios and Specifications
13.6.3 CAPNIA, Inc. Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CAPNIA, Inc. Main Business Overview
13.6.5 CAPNIA, Inc. Latest Developments
13.7 Kibion??
13.7.1 Kibion?? Company Information
13.7.2 Kibion?? Breath Molecular Diagnosis Product Portfolios and Specifications
13.7.3 Kibion?? Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Kibion?? Main Business Overview
13.7.5 Kibion?? Latest Developments
13.8 Otsuka Electronics
13.8.1 Otsuka Electronics Company Information
13.8.2 Otsuka Electronics Breath Molecular Diagnosis Product Portfolios and Specifications
13.8.3 Otsuka Electronics Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Otsuka Electronics Main Business Overview
13.8.5 Otsuka Electronics Latest Developments
13.9 LEYI BIOLOGY
13.9.1 LEYI BIOLOGY Company Information
13.9.2 LEYI BIOLOGY Breath Molecular Diagnosis Product Portfolios and Specifications
13.9.3 LEYI BIOLOGY Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 LEYI BIOLOGY Main Business Overview
13.9.5 LEYI BIOLOGY Latest Developments
13.10 Eco Physics AG
13.10.1 Eco Physics AG Company Information
13.10.2 Eco Physics AG Breath Molecular Diagnosis Product Portfolios and Specifications
13.10.3 Eco Physics AG Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Eco Physics AG Main Business Overview
13.10.5 Eco Physics AG Latest Developments
13.11 Shenzhen Breax
13.11.1 Shenzhen Breax Company Information
13.11.2 Shenzhen Breax Breath Molecular Diagnosis Product Portfolios and Specifications
13.11.3 Shenzhen Breax Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shenzhen Breax Main Business Overview
13.11.5 Shenzhen Breax Latest Developments
13.12 QUINTRON
13.12.1 QUINTRON Company Information
13.12.2 QUINTRON Breath Molecular Diagnosis Product Portfolios and Specifications
13.12.3 QUINTRON Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 QUINTRON Main Business Overview
13.12.5 QUINTRON Latest Developments
13.13 Beijing Wanliandaxinke Instruments Co
13.13.1 Beijing Wanliandaxinke Instruments Co Company Information
13.13.2 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Product Portfolios and Specifications
13.13.3 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Beijing Wanliandaxinke Instruments Co Main Business Overview
13.13.5 Beijing Wanliandaxinke Instruments Co Latest Developments
13.14 SIMES SIKMA
13.14.1 SIMES SIKMA Company Information
13.14.2 SIMES SIKMA Breath Molecular Diagnosis Product Portfolios and Specifications
13.14.3 SIMES SIKMA Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 SIMES SIKMA Main Business Overview
13.14.5 SIMES SIKMA Latest Developments
13.15 Beijing Safe Heart Technology
13.15.1 Beijing Safe Heart Technology Company Information
13.15.2 Beijing Safe Heart Technology Breath Molecular Diagnosis Product Portfolios and Specifications
13.15.3 Beijing Safe Heart Technology Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Beijing Safe Heart Technology Main Business Overview
13.15.5 Beijing Safe Heart Technology Latest Developments
13.16 e-LinkCare Meditech Co
13.16.1 e-LinkCare Meditech Co Company Information
13.16.2 e-LinkCare Meditech Co Breath Molecular Diagnosis Product Portfolios and Specifications
13.16.3 e-LinkCare Meditech Co Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 e-LinkCare Meditech Co Main Business Overview
13.16.5 e-LinkCare Meditech Co Latest Developments
13.17 ChromX Health
13.17.1 ChromX Health Company Information
13.17.2 ChromX Health Breath Molecular Diagnosis Product Portfolios and Specifications
13.17.3 ChromX Health Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 ChromX Health Main Business Overview
13.17.5 ChromX Health Latest Developments
13.18 Huiyuen Tech
13.18.1 Huiyuen Tech Company Information
13.18.2 Huiyuen Tech Breath Molecular Diagnosis Product Portfolios and Specifications
13.18.3 Huiyuen Tech Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Huiyuen Tech Main Business Overview
13.18.5 Huiyuen Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Breath Molecular Diagnosis Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Breath Molecular Diagnosis by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Breath Molecular Diagnosis by Country/Region, 2020, 2024 & 2031
2.2 Breath Molecular Diagnosis Segment by Type
2.2.1 C13 Type
2.2.2 NO Type
2.2.3 H2/CO Type
2.2.4 VOCs Type
2.3 Breath Molecular Diagnosis Sales by Type
2.3.1 Global Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
2.3.2 Global Breath Molecular Diagnosis Revenue and Market Share by Type (2020-2025)
2.3.3 Global Breath Molecular Diagnosis Sale Price by Type (2020-2025)
2.4 Breath Molecular Diagnosis Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Physical Examination Center
2.4.4 Other
2.5 Breath Molecular Diagnosis Sales by Application
2.5.1 Global Breath Molecular Diagnosis Sale Market Share by Application (2020-2025)
2.5.2 Global Breath Molecular Diagnosis Revenue and Market Share by Application (2020-2025)
2.5.3 Global Breath Molecular Diagnosis Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Breath Molecular Diagnosis Breakdown Data by Company
3.1.1 Global Breath Molecular Diagnosis Annual Sales by Company (2020-2025)
3.1.2 Global Breath Molecular Diagnosis Sales Market Share by Company (2020-2025)
3.2 Global Breath Molecular Diagnosis Annual Revenue by Company (2020-2025)
3.2.1 Global Breath Molecular Diagnosis Revenue by Company (2020-2025)
3.2.2 Global Breath Molecular Diagnosis Revenue Market Share by Company (2020-2025)
3.3 Global Breath Molecular Diagnosis Sale Price by Company
3.4 Key Manufacturers Breath Molecular Diagnosis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Breath Molecular Diagnosis Product Location Distribution
3.4.2 Players Breath Molecular Diagnosis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BREATH MOLECULAR DIAGNOSIS BY GEOGRAPHIC REGION
4.1 World Historic Breath Molecular Diagnosis Market Size by Geographic Region (2020-2025)
4.1.1 Global Breath Molecular Diagnosis Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Breath Molecular Diagnosis Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Breath Molecular Diagnosis Market Size by Country/Region (2020-2025)
4.2.1 Global Breath Molecular Diagnosis Annual Sales by Country/Region (2020-2025)
4.2.2 Global Breath Molecular Diagnosis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Breath Molecular Diagnosis Sales Growth
4.4 APAC Breath Molecular Diagnosis Sales Growth
4.5 Europe Breath Molecular Diagnosis Sales Growth
4.6 Middle East & Africa Breath Molecular Diagnosis Sales Growth
5 AMERICAS
5.1 Americas Breath Molecular Diagnosis Sales by Country
5.1.1 Americas Breath Molecular Diagnosis Sales by Country (2020-2025)
5.1.2 Americas Breath Molecular Diagnosis Revenue by Country (2020-2025)
5.2 Americas Breath Molecular Diagnosis Sales by Type (2020-2025)
5.3 Americas Breath Molecular Diagnosis Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breath Molecular Diagnosis Sales by Region
6.1.1 APAC Breath Molecular Diagnosis Sales by Region (2020-2025)
6.1.2 APAC Breath Molecular Diagnosis Revenue by Region (2020-2025)
6.2 APAC Breath Molecular Diagnosis Sales by Type (2020-2025)
6.3 APAC Breath Molecular Diagnosis Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Breath Molecular Diagnosis by Country
7.1.1 Europe Breath Molecular Diagnosis Sales by Country (2020-2025)
7.1.2 Europe Breath Molecular Diagnosis Revenue by Country (2020-2025)
7.2 Europe Breath Molecular Diagnosis Sales by Type (2020-2025)
7.3 Europe Breath Molecular Diagnosis Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Breath Molecular Diagnosis by Country
8.1.1 Middle East & Africa Breath Molecular Diagnosis Sales by Country (2020-2025)
8.1.2 Middle East & Africa Breath Molecular Diagnosis Revenue by Country (2020-2025)
8.2 Middle East & Africa Breath Molecular Diagnosis Sales by Type (2020-2025)
8.3 Middle East & Africa Breath Molecular Diagnosis Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Breath Molecular Diagnosis
10.3 Manufacturing Process Analysis of Breath Molecular Diagnosis
10.4 Industry Chain Structure of Breath Molecular Diagnosis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Breath Molecular Diagnosis Distributors
11.3 Breath Molecular Diagnosis Customer
12 WORLD FORECAST REVIEW FOR BREATH MOLECULAR DIAGNOSIS BY GEOGRAPHIC REGION
12.1 Global Breath Molecular Diagnosis Market Size Forecast by Region
12.1.1 Global Breath Molecular Diagnosis Forecast by Region (2026-2031)
12.1.2 Global Breath Molecular Diagnosis Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Breath Molecular Diagnosis Forecast by Type (2026-2031)
12.7 Global Breath Molecular Diagnosis Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 NIOX Group plc
13.1.1 NIOX Group plc Company Information
13.1.2 NIOX Group plc Breath Molecular Diagnosis Product Portfolios and Specifications
13.1.3 NIOX Group plc Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 NIOX Group plc Main Business Overview
13.1.5 NIOX Group plc Latest Developments
13.2 Headway
13.2.1 Headway Company Information
13.2.2 Headway Breath Molecular Diagnosis Product Portfolios and Specifications
13.2.3 Headway Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Headway Main Business Overview
13.2.5 Headway Latest Developments
13.3 Sunvou Medical Electronics Co
13.3.1 Sunvou Medical Electronics Co Company Information
13.3.2 Sunvou Medical Electronics Co Breath Molecular Diagnosis Product Portfolios and Specifications
13.3.3 Sunvou Medical Electronics Co Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sunvou Medical Electronics Co Main Business Overview
13.3.5 Sunvou Medical Electronics Co Latest Developments
13.4 Richen Holding
13.4.1 Richen Holding Company Information
13.4.2 Richen Holding Breath Molecular Diagnosis Product Portfolios and Specifications
13.4.3 Richen Holding Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Richen Holding Main Business Overview
13.4.5 Richen Holding Latest Developments
13.5 Meridian Bioscience
13.5.1 Meridian Bioscience Company Information
13.5.2 Meridian Bioscience Breath Molecular Diagnosis Product Portfolios and Specifications
13.5.3 Meridian Bioscience Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Meridian Bioscience Main Business Overview
13.5.5 Meridian Bioscience Latest Developments
13.6 CAPNIA, Inc.
13.6.1 CAPNIA, Inc. Company Information
13.6.2 CAPNIA, Inc. Breath Molecular Diagnosis Product Portfolios and Specifications
13.6.3 CAPNIA, Inc. Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CAPNIA, Inc. Main Business Overview
13.6.5 CAPNIA, Inc. Latest Developments
13.7 Kibion??
13.7.1 Kibion?? Company Information
13.7.2 Kibion?? Breath Molecular Diagnosis Product Portfolios and Specifications
13.7.3 Kibion?? Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Kibion?? Main Business Overview
13.7.5 Kibion?? Latest Developments
13.8 Otsuka Electronics
13.8.1 Otsuka Electronics Company Information
13.8.2 Otsuka Electronics Breath Molecular Diagnosis Product Portfolios and Specifications
13.8.3 Otsuka Electronics Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Otsuka Electronics Main Business Overview
13.8.5 Otsuka Electronics Latest Developments
13.9 LEYI BIOLOGY
13.9.1 LEYI BIOLOGY Company Information
13.9.2 LEYI BIOLOGY Breath Molecular Diagnosis Product Portfolios and Specifications
13.9.3 LEYI BIOLOGY Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 LEYI BIOLOGY Main Business Overview
13.9.5 LEYI BIOLOGY Latest Developments
13.10 Eco Physics AG
13.10.1 Eco Physics AG Company Information
13.10.2 Eco Physics AG Breath Molecular Diagnosis Product Portfolios and Specifications
13.10.3 Eco Physics AG Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Eco Physics AG Main Business Overview
13.10.5 Eco Physics AG Latest Developments
13.11 Shenzhen Breax
13.11.1 Shenzhen Breax Company Information
13.11.2 Shenzhen Breax Breath Molecular Diagnosis Product Portfolios and Specifications
13.11.3 Shenzhen Breax Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shenzhen Breax Main Business Overview
13.11.5 Shenzhen Breax Latest Developments
13.12 QUINTRON
13.12.1 QUINTRON Company Information
13.12.2 QUINTRON Breath Molecular Diagnosis Product Portfolios and Specifications
13.12.3 QUINTRON Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 QUINTRON Main Business Overview
13.12.5 QUINTRON Latest Developments
13.13 Beijing Wanliandaxinke Instruments Co
13.13.1 Beijing Wanliandaxinke Instruments Co Company Information
13.13.2 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Product Portfolios and Specifications
13.13.3 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Beijing Wanliandaxinke Instruments Co Main Business Overview
13.13.5 Beijing Wanliandaxinke Instruments Co Latest Developments
13.14 SIMES SIKMA
13.14.1 SIMES SIKMA Company Information
13.14.2 SIMES SIKMA Breath Molecular Diagnosis Product Portfolios and Specifications
13.14.3 SIMES SIKMA Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 SIMES SIKMA Main Business Overview
13.14.5 SIMES SIKMA Latest Developments
13.15 Beijing Safe Heart Technology
13.15.1 Beijing Safe Heart Technology Company Information
13.15.2 Beijing Safe Heart Technology Breath Molecular Diagnosis Product Portfolios and Specifications
13.15.3 Beijing Safe Heart Technology Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Beijing Safe Heart Technology Main Business Overview
13.15.5 Beijing Safe Heart Technology Latest Developments
13.16 e-LinkCare Meditech Co
13.16.1 e-LinkCare Meditech Co Company Information
13.16.2 e-LinkCare Meditech Co Breath Molecular Diagnosis Product Portfolios and Specifications
13.16.3 e-LinkCare Meditech Co Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 e-LinkCare Meditech Co Main Business Overview
13.16.5 e-LinkCare Meditech Co Latest Developments
13.17 ChromX Health
13.17.1 ChromX Health Company Information
13.17.2 ChromX Health Breath Molecular Diagnosis Product Portfolios and Specifications
13.17.3 ChromX Health Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 ChromX Health Main Business Overview
13.17.5 ChromX Health Latest Developments
13.18 Huiyuen Tech
13.18.1 Huiyuen Tech Company Information
13.18.2 Huiyuen Tech Breath Molecular Diagnosis Product Portfolios and Specifications
13.18.3 Huiyuen Tech Breath Molecular Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Huiyuen Tech Main Business Overview
13.18.5 Huiyuen Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Breath Molecular Diagnosis Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Breath Molecular Diagnosis Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of C13 Type
Table 4. Major Players of NO Type
Table 5. Major Players of H2/CO Type
Table 6. Major Players of VOCs Type
Table 7. Global Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 8. Global Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Table 9. Global Breath Molecular Diagnosis Revenue by Type (2020-2025) & ($ million)
Table 10. Global Breath Molecular Diagnosis Revenue Market Share by Type (2020-2025)
Table 11. Global Breath Molecular Diagnosis Sale Price by Type (2020-2025) & (US$/Unit)
Table 12. Global Breath Molecular Diagnosis Sale by Application (2020-2025) & (K Units)
Table 13. Global Breath Molecular Diagnosis Sale Market Share by Application (2020-2025)
Table 14. Global Breath Molecular Diagnosis Revenue by Application (2020-2025) & ($ million)
Table 15. Global Breath Molecular Diagnosis Revenue Market Share by Application (2020-2025)
Table 16. Global Breath Molecular Diagnosis Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Breath Molecular Diagnosis Sales by Company (2020-2025) & (K Units)
Table 18. Global Breath Molecular Diagnosis Sales Market Share by Company (2020-2025)
Table 19. Global Breath Molecular Diagnosis Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Breath Molecular Diagnosis Revenue Market Share by Company (2020-2025)
Table 21. Global Breath Molecular Diagnosis Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Breath Molecular Diagnosis Producing Area Distribution and Sales Area
Table 23. Players Breath Molecular Diagnosis Products Offered
Table 24. Breath Molecular Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Breath Molecular Diagnosis Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Breath Molecular Diagnosis Sales Market Share Geographic Region (2020-2025)
Table 29. Global Breath Molecular Diagnosis Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Breath Molecular Diagnosis Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Breath Molecular Diagnosis Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Breath Molecular Diagnosis Sales Market Share by Country/Region (2020-2025)
Table 33. Global Breath Molecular Diagnosis Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Breath Molecular Diagnosis Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
Table 36. Americas Breath Molecular Diagnosis Sales Market Share by Country (2020-2025)
Table 37. Americas Breath Molecular Diagnosis Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 39. Americas Breath Molecular Diagnosis Sales by Application (2020-2025) & (K Units)
Table 40. APAC Breath Molecular Diagnosis Sales by Region (2020-2025) & (K Units)
Table 41. APAC Breath Molecular Diagnosis Sales Market Share by Region (2020-2025)
Table 42. APAC Breath Molecular Diagnosis Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 44. APAC Breath Molecular Diagnosis Sales by Application (2020-2025) & (K Units)
Table 45. Europe Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
Table 46. Europe Breath Molecular Diagnosis Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 48. Europe Breath Molecular Diagnosis Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Breath Molecular Diagnosis Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Breath Molecular Diagnosis Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Breath Molecular Diagnosis
Table 54. Key Market Challenges & Risks of Breath Molecular Diagnosis
Table 55. Key Industry Trends of Breath Molecular Diagnosis
Table 56. Breath Molecular Diagnosis Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Breath Molecular Diagnosis Distributors List
Table 59. Breath Molecular Diagnosis Customer List
Table 60. Global Breath Molecular Diagnosis Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Breath Molecular Diagnosis Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Breath Molecular Diagnosis Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Breath Molecular Diagnosis Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Breath Molecular Diagnosis Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Breath Molecular Diagnosis Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Breath Molecular Diagnosis Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Breath Molecular Diagnosis Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Breath Molecular Diagnosis Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Breath Molecular Diagnosis Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Breath Molecular Diagnosis Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Breath Molecular Diagnosis Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Breath Molecular Diagnosis Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Breath Molecular Diagnosis Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. NIOX Group plc Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 75. NIOX Group plc Breath Molecular Diagnosis Product Portfolios and Specifications
Table 76. NIOX Group plc Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. NIOX Group plc Main Business
Table 78. NIOX Group plc Latest Developments
Table 79. Headway Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 80. Headway Breath Molecular Diagnosis Product Portfolios and Specifications
Table 81. Headway Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. Headway Main Business
Table 83. Headway Latest Developments
Table 84. Sunvou Medical Electronics Co Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 85. Sunvou Medical Electronics Co Breath Molecular Diagnosis Product Portfolios and Specifications
Table 86. Sunvou Medical Electronics Co Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Sunvou Medical Electronics Co Main Business
Table 88. Sunvou Medical Electronics Co Latest Developments
Table 89. Richen Holding Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 90. Richen Holding Breath Molecular Diagnosis Product Portfolios and Specifications
Table 91. Richen Holding Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Richen Holding Main Business
Table 93. Richen Holding Latest Developments
Table 94. Meridian Bioscience Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 95. Meridian Bioscience Breath Molecular Diagnosis Product Portfolios and Specifications
Table 96. Meridian Bioscience Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Meridian Bioscience Main Business
Table 98. Meridian Bioscience Latest Developments
Table 99. CAPNIA, Inc. Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 100. CAPNIA, Inc. Breath Molecular Diagnosis Product Portfolios and Specifications
Table 101. CAPNIA, Inc. Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. CAPNIA, Inc. Main Business
Table 103. CAPNIA, Inc. Latest Developments
Table 104. Kibion?? Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 105. Kibion?? Breath Molecular Diagnosis Product Portfolios and Specifications
Table 106. Kibion?? Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. Kibion?? Main Business
Table 108. Kibion?? Latest Developments
Table 109. Otsuka Electronics Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 110. Otsuka Electronics Breath Molecular Diagnosis Product Portfolios and Specifications
Table 111. Otsuka Electronics Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Otsuka Electronics Main Business
Table 113. Otsuka Electronics Latest Developments
Table 114. LEYI BIOLOGY Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 115. LEYI BIOLOGY Breath Molecular Diagnosis Product Portfolios and Specifications
Table 116. LEYI BIOLOGY Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. LEYI BIOLOGY Main Business
Table 118. LEYI BIOLOGY Latest Developments
Table 119. Eco Physics AG Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 120. Eco Physics AG Breath Molecular Diagnosis Product Portfolios and Specifications
Table 121. Eco Physics AG Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. Eco Physics AG Main Business
Table 123. Eco Physics AG Latest Developments
Table 124. Shenzhen Breax Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 125. Shenzhen Breax Breath Molecular Diagnosis Product Portfolios and Specifications
Table 126. Shenzhen Breax Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 127. Shenzhen Breax Main Business
Table 128. Shenzhen Breax Latest Developments
Table 129. QUINTRON Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 130. QUINTRON Breath Molecular Diagnosis Product Portfolios and Specifications
Table 131. QUINTRON Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 132. QUINTRON Main Business
Table 133. QUINTRON Latest Developments
Table 134. Beijing Wanliandaxinke Instruments Co Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 135. Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Product Portfolios and Specifications
Table 136. Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 137. Beijing Wanliandaxinke Instruments Co Main Business
Table 138. Beijing Wanliandaxinke Instruments Co Latest Developments
Table 139. SIMES SIKMA Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 140. SIMES SIKMA Breath Molecular Diagnosis Product Portfolios and Specifications
Table 141. SIMES SIKMA Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 142. SIMES SIKMA Main Business
Table 143. SIMES SIKMA Latest Developments
Table 144. Beijing Safe Heart Technology Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 145. Beijing Safe Heart Technology Breath Molecular Diagnosis Product Portfolios and Specifications
Table 146. Beijing Safe Heart Technology Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 147. Beijing Safe Heart Technology Main Business
Table 148. Beijing Safe Heart Technology Latest Developments
Table 149. e-LinkCare Meditech Co Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 150. e-LinkCare Meditech Co Breath Molecular Diagnosis Product Portfolios and Specifications
Table 151. e-LinkCare Meditech Co Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 152. e-LinkCare Meditech Co Main Business
Table 153. e-LinkCare Meditech Co Latest Developments
Table 154. ChromX Health Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 155. ChromX Health Breath Molecular Diagnosis Product Portfolios and Specifications
Table 156. ChromX Health Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 157. ChromX Health Main Business
Table 158. ChromX Health Latest Developments
Table 159. Huiyuen Tech Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 160. Huiyuen Tech Breath Molecular Diagnosis Product Portfolios and Specifications
Table 161. Huiyuen Tech Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 162. Huiyuen Tech Main Business
Table 163. Huiyuen Tech Latest Developments
Table 1. Breath Molecular Diagnosis Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Breath Molecular Diagnosis Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of C13 Type
Table 4. Major Players of NO Type
Table 5. Major Players of H2/CO Type
Table 6. Major Players of VOCs Type
Table 7. Global Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 8. Global Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Table 9. Global Breath Molecular Diagnosis Revenue by Type (2020-2025) & ($ million)
Table 10. Global Breath Molecular Diagnosis Revenue Market Share by Type (2020-2025)
Table 11. Global Breath Molecular Diagnosis Sale Price by Type (2020-2025) & (US$/Unit)
Table 12. Global Breath Molecular Diagnosis Sale by Application (2020-2025) & (K Units)
Table 13. Global Breath Molecular Diagnosis Sale Market Share by Application (2020-2025)
Table 14. Global Breath Molecular Diagnosis Revenue by Application (2020-2025) & ($ million)
Table 15. Global Breath Molecular Diagnosis Revenue Market Share by Application (2020-2025)
Table 16. Global Breath Molecular Diagnosis Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Breath Molecular Diagnosis Sales by Company (2020-2025) & (K Units)
Table 18. Global Breath Molecular Diagnosis Sales Market Share by Company (2020-2025)
Table 19. Global Breath Molecular Diagnosis Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Breath Molecular Diagnosis Revenue Market Share by Company (2020-2025)
Table 21. Global Breath Molecular Diagnosis Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Breath Molecular Diagnosis Producing Area Distribution and Sales Area
Table 23. Players Breath Molecular Diagnosis Products Offered
Table 24. Breath Molecular Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Breath Molecular Diagnosis Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Breath Molecular Diagnosis Sales Market Share Geographic Region (2020-2025)
Table 29. Global Breath Molecular Diagnosis Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Breath Molecular Diagnosis Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Breath Molecular Diagnosis Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Breath Molecular Diagnosis Sales Market Share by Country/Region (2020-2025)
Table 33. Global Breath Molecular Diagnosis Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Breath Molecular Diagnosis Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
Table 36. Americas Breath Molecular Diagnosis Sales Market Share by Country (2020-2025)
Table 37. Americas Breath Molecular Diagnosis Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 39. Americas Breath Molecular Diagnosis Sales by Application (2020-2025) & (K Units)
Table 40. APAC Breath Molecular Diagnosis Sales by Region (2020-2025) & (K Units)
Table 41. APAC Breath Molecular Diagnosis Sales Market Share by Region (2020-2025)
Table 42. APAC Breath Molecular Diagnosis Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 44. APAC Breath Molecular Diagnosis Sales by Application (2020-2025) & (K Units)
Table 45. Europe Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
Table 46. Europe Breath Molecular Diagnosis Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 48. Europe Breath Molecular Diagnosis Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Breath Molecular Diagnosis Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Breath Molecular Diagnosis Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Breath Molecular Diagnosis Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Breath Molecular Diagnosis
Table 54. Key Market Challenges & Risks of Breath Molecular Diagnosis
Table 55. Key Industry Trends of Breath Molecular Diagnosis
Table 56. Breath Molecular Diagnosis Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Breath Molecular Diagnosis Distributors List
Table 59. Breath Molecular Diagnosis Customer List
Table 60. Global Breath Molecular Diagnosis Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Breath Molecular Diagnosis Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Breath Molecular Diagnosis Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Breath Molecular Diagnosis Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Breath Molecular Diagnosis Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Breath Molecular Diagnosis Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Breath Molecular Diagnosis Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Breath Molecular Diagnosis Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Breath Molecular Diagnosis Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Breath Molecular Diagnosis Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Breath Molecular Diagnosis Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Breath Molecular Diagnosis Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Breath Molecular Diagnosis Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Breath Molecular Diagnosis Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. NIOX Group plc Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 75. NIOX Group plc Breath Molecular Diagnosis Product Portfolios and Specifications
Table 76. NIOX Group plc Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. NIOX Group plc Main Business
Table 78. NIOX Group plc Latest Developments
Table 79. Headway Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 80. Headway Breath Molecular Diagnosis Product Portfolios and Specifications
Table 81. Headway Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. Headway Main Business
Table 83. Headway Latest Developments
Table 84. Sunvou Medical Electronics Co Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 85. Sunvou Medical Electronics Co Breath Molecular Diagnosis Product Portfolios and Specifications
Table 86. Sunvou Medical Electronics Co Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Sunvou Medical Electronics Co Main Business
Table 88. Sunvou Medical Electronics Co Latest Developments
Table 89. Richen Holding Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 90. Richen Holding Breath Molecular Diagnosis Product Portfolios and Specifications
Table 91. Richen Holding Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Richen Holding Main Business
Table 93. Richen Holding Latest Developments
Table 94. Meridian Bioscience Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 95. Meridian Bioscience Breath Molecular Diagnosis Product Portfolios and Specifications
Table 96. Meridian Bioscience Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Meridian Bioscience Main Business
Table 98. Meridian Bioscience Latest Developments
Table 99. CAPNIA, Inc. Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 100. CAPNIA, Inc. Breath Molecular Diagnosis Product Portfolios and Specifications
Table 101. CAPNIA, Inc. Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. CAPNIA, Inc. Main Business
Table 103. CAPNIA, Inc. Latest Developments
Table 104. Kibion?? Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 105. Kibion?? Breath Molecular Diagnosis Product Portfolios and Specifications
Table 106. Kibion?? Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. Kibion?? Main Business
Table 108. Kibion?? Latest Developments
Table 109. Otsuka Electronics Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 110. Otsuka Electronics Breath Molecular Diagnosis Product Portfolios and Specifications
Table 111. Otsuka Electronics Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Otsuka Electronics Main Business
Table 113. Otsuka Electronics Latest Developments
Table 114. LEYI BIOLOGY Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 115. LEYI BIOLOGY Breath Molecular Diagnosis Product Portfolios and Specifications
Table 116. LEYI BIOLOGY Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. LEYI BIOLOGY Main Business
Table 118. LEYI BIOLOGY Latest Developments
Table 119. Eco Physics AG Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 120. Eco Physics AG Breath Molecular Diagnosis Product Portfolios and Specifications
Table 121. Eco Physics AG Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. Eco Physics AG Main Business
Table 123. Eco Physics AG Latest Developments
Table 124. Shenzhen Breax Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 125. Shenzhen Breax Breath Molecular Diagnosis Product Portfolios and Specifications
Table 126. Shenzhen Breax Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 127. Shenzhen Breax Main Business
Table 128. Shenzhen Breax Latest Developments
Table 129. QUINTRON Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 130. QUINTRON Breath Molecular Diagnosis Product Portfolios and Specifications
Table 131. QUINTRON Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 132. QUINTRON Main Business
Table 133. QUINTRON Latest Developments
Table 134. Beijing Wanliandaxinke Instruments Co Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 135. Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Product Portfolios and Specifications
Table 136. Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 137. Beijing Wanliandaxinke Instruments Co Main Business
Table 138. Beijing Wanliandaxinke Instruments Co Latest Developments
Table 139. SIMES SIKMA Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 140. SIMES SIKMA Breath Molecular Diagnosis Product Portfolios and Specifications
Table 141. SIMES SIKMA Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 142. SIMES SIKMA Main Business
Table 143. SIMES SIKMA Latest Developments
Table 144. Beijing Safe Heart Technology Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 145. Beijing Safe Heart Technology Breath Molecular Diagnosis Product Portfolios and Specifications
Table 146. Beijing Safe Heart Technology Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 147. Beijing Safe Heart Technology Main Business
Table 148. Beijing Safe Heart Technology Latest Developments
Table 149. e-LinkCare Meditech Co Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 150. e-LinkCare Meditech Co Breath Molecular Diagnosis Product Portfolios and Specifications
Table 151. e-LinkCare Meditech Co Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 152. e-LinkCare Meditech Co Main Business
Table 153. e-LinkCare Meditech Co Latest Developments
Table 154. ChromX Health Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 155. ChromX Health Breath Molecular Diagnosis Product Portfolios and Specifications
Table 156. ChromX Health Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 157. ChromX Health Main Business
Table 158. ChromX Health Latest Developments
Table 159. Huiyuen Tech Basic Information, Breath Molecular Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 160. Huiyuen Tech Breath Molecular Diagnosis Product Portfolios and Specifications
Table 161. Huiyuen Tech Breath Molecular Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 162. Huiyuen Tech Main Business
Table 163. Huiyuen Tech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Breath Molecular Diagnosis
Figure 2. Breath Molecular Diagnosis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Breath Molecular Diagnosis Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Breath Molecular Diagnosis Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Breath Molecular Diagnosis Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Breath Molecular Diagnosis Sales Market Share by Country/Region (2024)
Figure 10. Breath Molecular Diagnosis Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of C13 Type
Figure 12. Product Picture of NO Type
Figure 13. Product Picture of H2/CO Type
Figure 14. Product Picture of VOCs Type
Figure 15. Global Breath Molecular Diagnosis Sales Market Share by Type in 2025
Figure 16. Global Breath Molecular Diagnosis Revenue Market Share by Type (2020-2025)
Figure 17. Breath Molecular Diagnosis Consumed in Hospital
Figure 18. Global Breath Molecular Diagnosis Market: Hospital (2020-2025) & (K Units)
Figure 19. Breath Molecular Diagnosis Consumed in Clinic
Figure 20. Global Breath Molecular Diagnosis Market: Clinic (2020-2025) & (K Units)
Figure 21. Breath Molecular Diagnosis Consumed in Physical Examination Center
Figure 22. Global Breath Molecular Diagnosis Market: Physical Examination Center (2020-2025) & (K Units)
Figure 23. Breath Molecular Diagnosis Consumed in Other
Figure 24. Global Breath Molecular Diagnosis Market: Other (2020-2025) & (K Units)
Figure 25. Global Breath Molecular Diagnosis Sale Market Share by Application (2024)
Figure 26. Global Breath Molecular Diagnosis Revenue Market Share by Application in 2025
Figure 27. Breath Molecular Diagnosis Sales by Company in 2025 (K Units)
Figure 28. Global Breath Molecular Diagnosis Sales Market Share by Company in 2025
Figure 29. Breath Molecular Diagnosis Revenue by Company in 2025 ($ millions)
Figure 30. Global Breath Molecular Diagnosis Revenue Market Share by Company in 2025
Figure 31. Global Breath Molecular Diagnosis Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Breath Molecular Diagnosis Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Breath Molecular Diagnosis Sales 2020-2025 (K Units)
Figure 34. Americas Breath Molecular Diagnosis Revenue 2020-2025 ($ millions)
Figure 35. APAC Breath Molecular Diagnosis Sales 2020-2025 (K Units)
Figure 36. APAC Breath Molecular Diagnosis Revenue 2020-2025 ($ millions)
Figure 37. Europe Breath Molecular Diagnosis Sales 2020-2025 (K Units)
Figure 38. Europe Breath Molecular Diagnosis Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Breath Molecular Diagnosis Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Breath Molecular Diagnosis Revenue 2020-2025 ($ millions)
Figure 41. Americas Breath Molecular Diagnosis Sales Market Share by Country in 2025
Figure 42. Americas Breath Molecular Diagnosis Revenue Market Share by Country (2020-2025)
Figure 43. Americas Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Figure 44. Americas Breath Molecular Diagnosis Sales Market Share by Application (2020-2025)
Figure 45. United States Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Breath Molecular Diagnosis Sales Market Share by Region in 2025
Figure 50. APAC Breath Molecular Diagnosis Revenue Market Share by Region (2020-2025)
Figure 51. APAC Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Figure 52. APAC Breath Molecular Diagnosis Sales Market Share by Application (2020-2025)
Figure 53. China Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 57. India Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Breath Molecular Diagnosis Sales Market Share by Country in 2025
Figure 61. Europe Breath Molecular Diagnosis Revenue Market Share by Country (2020-2025)
Figure 62. Europe Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Figure 63. Europe Breath Molecular Diagnosis Sales Market Share by Application (2020-2025)
Figure 64. Germany Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 65. France Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Breath Molecular Diagnosis Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Breath Molecular Diagnosis Sales Market Share by Application (2020-2025)
Figure 72. Egypt Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Breath Molecular Diagnosis in 2025
Figure 78. Manufacturing Process Analysis of Breath Molecular Diagnosis
Figure 79. Industry Chain Structure of Breath Molecular Diagnosis
Figure 80. Channels of Distribution
Figure 81. Global Breath Molecular Diagnosis Sales Market Forecast by Region (2026-2031)
Figure 82. Global Breath Molecular Diagnosis Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Breath Molecular Diagnosis Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Breath Molecular Diagnosis Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Breath Molecular Diagnosis Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Breath Molecular Diagnosis Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Breath Molecular Diagnosis
Figure 2. Breath Molecular Diagnosis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Breath Molecular Diagnosis Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Breath Molecular Diagnosis Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Breath Molecular Diagnosis Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Breath Molecular Diagnosis Sales Market Share by Country/Region (2024)
Figure 10. Breath Molecular Diagnosis Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of C13 Type
Figure 12. Product Picture of NO Type
Figure 13. Product Picture of H2/CO Type
Figure 14. Product Picture of VOCs Type
Figure 15. Global Breath Molecular Diagnosis Sales Market Share by Type in 2025
Figure 16. Global Breath Molecular Diagnosis Revenue Market Share by Type (2020-2025)
Figure 17. Breath Molecular Diagnosis Consumed in Hospital
Figure 18. Global Breath Molecular Diagnosis Market: Hospital (2020-2025) & (K Units)
Figure 19. Breath Molecular Diagnosis Consumed in Clinic
Figure 20. Global Breath Molecular Diagnosis Market: Clinic (2020-2025) & (K Units)
Figure 21. Breath Molecular Diagnosis Consumed in Physical Examination Center
Figure 22. Global Breath Molecular Diagnosis Market: Physical Examination Center (2020-2025) & (K Units)
Figure 23. Breath Molecular Diagnosis Consumed in Other
Figure 24. Global Breath Molecular Diagnosis Market: Other (2020-2025) & (K Units)
Figure 25. Global Breath Molecular Diagnosis Sale Market Share by Application (2024)
Figure 26. Global Breath Molecular Diagnosis Revenue Market Share by Application in 2025
Figure 27. Breath Molecular Diagnosis Sales by Company in 2025 (K Units)
Figure 28. Global Breath Molecular Diagnosis Sales Market Share by Company in 2025
Figure 29. Breath Molecular Diagnosis Revenue by Company in 2025 ($ millions)
Figure 30. Global Breath Molecular Diagnosis Revenue Market Share by Company in 2025
Figure 31. Global Breath Molecular Diagnosis Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Breath Molecular Diagnosis Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Breath Molecular Diagnosis Sales 2020-2025 (K Units)
Figure 34. Americas Breath Molecular Diagnosis Revenue 2020-2025 ($ millions)
Figure 35. APAC Breath Molecular Diagnosis Sales 2020-2025 (K Units)
Figure 36. APAC Breath Molecular Diagnosis Revenue 2020-2025 ($ millions)
Figure 37. Europe Breath Molecular Diagnosis Sales 2020-2025 (K Units)
Figure 38. Europe Breath Molecular Diagnosis Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Breath Molecular Diagnosis Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Breath Molecular Diagnosis Revenue 2020-2025 ($ millions)
Figure 41. Americas Breath Molecular Diagnosis Sales Market Share by Country in 2025
Figure 42. Americas Breath Molecular Diagnosis Revenue Market Share by Country (2020-2025)
Figure 43. Americas Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Figure 44. Americas Breath Molecular Diagnosis Sales Market Share by Application (2020-2025)
Figure 45. United States Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Breath Molecular Diagnosis Sales Market Share by Region in 2025
Figure 50. APAC Breath Molecular Diagnosis Revenue Market Share by Region (2020-2025)
Figure 51. APAC Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Figure 52. APAC Breath Molecular Diagnosis Sales Market Share by Application (2020-2025)
Figure 53. China Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 57. India Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Breath Molecular Diagnosis Sales Market Share by Country in 2025
Figure 61. Europe Breath Molecular Diagnosis Revenue Market Share by Country (2020-2025)
Figure 62. Europe Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Figure 63. Europe Breath Molecular Diagnosis Sales Market Share by Application (2020-2025)
Figure 64. Germany Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 65. France Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Breath Molecular Diagnosis Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Breath Molecular Diagnosis Sales Market Share by Application (2020-2025)
Figure 72. Egypt Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Breath Molecular Diagnosis Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Breath Molecular Diagnosis in 2025
Figure 78. Manufacturing Process Analysis of Breath Molecular Diagnosis
Figure 79. Industry Chain Structure of Breath Molecular Diagnosis
Figure 80. Channels of Distribution
Figure 81. Global Breath Molecular Diagnosis Sales Market Forecast by Region (2026-2031)
Figure 82. Global Breath Molecular Diagnosis Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Breath Molecular Diagnosis Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Breath Molecular Diagnosis Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Breath Molecular Diagnosis Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Breath Molecular Diagnosis Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Oxymeter Market Growth 2024-2030
US$ 3,660.00
March 2024
115 pages
Global Sterile Water for Injection With Drugs Market Growth 2024-2030
US$ 3,660.00
June 2024
109 pages
Global Intravenous (IV) Ibuprofen Market Growth 2024-2030
US$ 3,660.00
March 2024
115 pages
Global Disease Risk and Health Test Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
159 pages
Global Biobank Sample Management and Storage System Market Growth 2023-2029
US$ 3,660.00
February 2023
94 pages
